|
Home Page >
Pharmaceutical
Litigation > Fen Phen
Fen Phen was prescribed for many years as an appetite
suppressant for the management of obesity. Fen Phen
is the combination of fenfluramine and phentermine. When these
two drugs were combined, now deemed defective drugs, they
formed fen Phen. Although these drugs proved to be harmful
causing heart valve damage, similar to the distinctive features
found in carcinoid syndrome, they were once legal prescription
drugs passed by the FDA.
It was not until the FDA answered to reports from numerous
clinics that patients taking Fen Phen were being diagnosed
with heart valve damage that they conducted defective drug
testing. Their findings were startling indicating that about
30% of asymptomatic patients had abnormal valve findings and
primary aortic regurgitation. To discover the heart valve
damage, or leakiness of the heart valves, an echocardiogram
must be performed by a cardiologist.
Fen Phen Side Effects include: heart valve damage, abnormal
hearth valves, leakiness of the heart valves, primary aortic
regurgitation, primary pulmonary hypertension (PPH), high
blood pressure and heart failure.
|
